Cargando…

Neurocognitive functioning in acute or early HIV infection

We examined neurocognitive functioning among persons with acute or early HIV infection (AEH) and hypothesized that the neurocognitive performance of AEH individuals would be intermediate between HIV seronegatives (HIV−) and those with chronic HIV infection. Comprehensive neurocognitive testing was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, David J., Letendre, Scott L., Morris, Sheldon, Umlauf, Anya, Deutsch, Reena, Smith, Davey M., Little, Susan, Rooney, Alexandra, Franklin, Donald R., Gouaux, Ben, LeBlanc, Shannon, Rosario, Debra, Fennema-Notestine, Christine, Heaton, Robert K., Ellis, Ronald J., Atkinson, J. Hampton, Grant, Igor
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032208/
https://www.ncbi.nlm.nih.gov/pubmed/21165782
http://dx.doi.org/10.1007/s13365-010-0009-y
_version_ 1782197429514272768
author Moore, David J.
Letendre, Scott L.
Morris, Sheldon
Umlauf, Anya
Deutsch, Reena
Smith, Davey M.
Little, Susan
Rooney, Alexandra
Franklin, Donald R.
Gouaux, Ben
LeBlanc, Shannon
Rosario, Debra
Fennema-Notestine, Christine
Heaton, Robert K.
Ellis, Ronald J.
Atkinson, J. Hampton
Grant, Igor
author_facet Moore, David J.
Letendre, Scott L.
Morris, Sheldon
Umlauf, Anya
Deutsch, Reena
Smith, Davey M.
Little, Susan
Rooney, Alexandra
Franklin, Donald R.
Gouaux, Ben
LeBlanc, Shannon
Rosario, Debra
Fennema-Notestine, Christine
Heaton, Robert K.
Ellis, Ronald J.
Atkinson, J. Hampton
Grant, Igor
author_sort Moore, David J.
collection PubMed
description We examined neurocognitive functioning among persons with acute or early HIV infection (AEH) and hypothesized that the neurocognitive performance of AEH individuals would be intermediate between HIV seronegatives (HIV−) and those with chronic HIV infection. Comprehensive neurocognitive testing was accomplished with 39 AEH, 63 chronically HIV infected, and 38 HIV− participants. All AEH participants were HIV infected for less than 1 year. Average domain deficit scores were calculated in seven neurocognitive domains. HIV−, AEH, and chronically HIV infected groups were ranked from best (rank of 1) to worst (rank of 3) in each domain. All participants received detailed substance use, neuromedical, and psychiatric evaluations and HIV infected persons provided information on antiretroviral treatment and completed laboratory evaluations including plasma and CSF viral loads. A nonparametric test of ordered alternatives (Page test), and the appropriate nonparametric follow-up test, was used to evaluate level of neuropsychological (NP) functioning across and between groups. The median duration of infection for the AEH group was 16 weeks [interquartile range, IQR: 10.3–40.7] as compared to 4.9 years [2.8–11.1] in the chronic HIV group. A Page test using ranks of average scores in the seven neurocognitive domains showed a significant monotonic trend with the best neurocognitive functioning in the HIV− group (mean rank = 1.43), intermediate neurocognitive functioning in the AEH group (mean rank = 1.71), and the worst in the chronically HIV infected (mean rank = 2.86; L statistic = 94, p < 0.01); however, post-hoc testing comparing neurocognitive impairment of each group against each of the other groups showed that the chronically infected group was significantly different from both the HIV− and AEH groups on neurocognitive performance; the AEH group was statistically indistinguishable from the HIV− group. Regression models among HIV infected participants were unable to identify significant predictors of neurocognitive performance. Neurocognitive functioning was worst among persons with chronic HIV infection. Although a significant monotonic trend existed and patterns of the data suggest the AEH individuals may fall intermediate to HIV− and chronic participants, we were not able to statistically confirm this hypothesis.
format Text
id pubmed-3032208
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-30322082011-03-16 Neurocognitive functioning in acute or early HIV infection Moore, David J. Letendre, Scott L. Morris, Sheldon Umlauf, Anya Deutsch, Reena Smith, Davey M. Little, Susan Rooney, Alexandra Franklin, Donald R. Gouaux, Ben LeBlanc, Shannon Rosario, Debra Fennema-Notestine, Christine Heaton, Robert K. Ellis, Ronald J. Atkinson, J. Hampton Grant, Igor J Neurovirol Article We examined neurocognitive functioning among persons with acute or early HIV infection (AEH) and hypothesized that the neurocognitive performance of AEH individuals would be intermediate between HIV seronegatives (HIV−) and those with chronic HIV infection. Comprehensive neurocognitive testing was accomplished with 39 AEH, 63 chronically HIV infected, and 38 HIV− participants. All AEH participants were HIV infected for less than 1 year. Average domain deficit scores were calculated in seven neurocognitive domains. HIV−, AEH, and chronically HIV infected groups were ranked from best (rank of 1) to worst (rank of 3) in each domain. All participants received detailed substance use, neuromedical, and psychiatric evaluations and HIV infected persons provided information on antiretroviral treatment and completed laboratory evaluations including plasma and CSF viral loads. A nonparametric test of ordered alternatives (Page test), and the appropriate nonparametric follow-up test, was used to evaluate level of neuropsychological (NP) functioning across and between groups. The median duration of infection for the AEH group was 16 weeks [interquartile range, IQR: 10.3–40.7] as compared to 4.9 years [2.8–11.1] in the chronic HIV group. A Page test using ranks of average scores in the seven neurocognitive domains showed a significant monotonic trend with the best neurocognitive functioning in the HIV− group (mean rank = 1.43), intermediate neurocognitive functioning in the AEH group (mean rank = 1.71), and the worst in the chronically HIV infected (mean rank = 2.86; L statistic = 94, p < 0.01); however, post-hoc testing comparing neurocognitive impairment of each group against each of the other groups showed that the chronically infected group was significantly different from both the HIV− and AEH groups on neurocognitive performance; the AEH group was statistically indistinguishable from the HIV− group. Regression models among HIV infected participants were unable to identify significant predictors of neurocognitive performance. Neurocognitive functioning was worst among persons with chronic HIV infection. Although a significant monotonic trend existed and patterns of the data suggest the AEH individuals may fall intermediate to HIV− and chronic participants, we were not able to statistically confirm this hypothesis. Springer US 2010-12-15 2011 /pmc/articles/PMC3032208/ /pubmed/21165782 http://dx.doi.org/10.1007/s13365-010-0009-y Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Moore, David J.
Letendre, Scott L.
Morris, Sheldon
Umlauf, Anya
Deutsch, Reena
Smith, Davey M.
Little, Susan
Rooney, Alexandra
Franklin, Donald R.
Gouaux, Ben
LeBlanc, Shannon
Rosario, Debra
Fennema-Notestine, Christine
Heaton, Robert K.
Ellis, Ronald J.
Atkinson, J. Hampton
Grant, Igor
Neurocognitive functioning in acute or early HIV infection
title Neurocognitive functioning in acute or early HIV infection
title_full Neurocognitive functioning in acute or early HIV infection
title_fullStr Neurocognitive functioning in acute or early HIV infection
title_full_unstemmed Neurocognitive functioning in acute or early HIV infection
title_short Neurocognitive functioning in acute or early HIV infection
title_sort neurocognitive functioning in acute or early hiv infection
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032208/
https://www.ncbi.nlm.nih.gov/pubmed/21165782
http://dx.doi.org/10.1007/s13365-010-0009-y
work_keys_str_mv AT mooredavidj neurocognitivefunctioninginacuteorearlyhivinfection
AT letendrescottl neurocognitivefunctioninginacuteorearlyhivinfection
AT morrissheldon neurocognitivefunctioninginacuteorearlyhivinfection
AT umlaufanya neurocognitivefunctioninginacuteorearlyhivinfection
AT deutschreena neurocognitivefunctioninginacuteorearlyhivinfection
AT smithdaveym neurocognitivefunctioninginacuteorearlyhivinfection
AT littlesusan neurocognitivefunctioninginacuteorearlyhivinfection
AT rooneyalexandra neurocognitivefunctioninginacuteorearlyhivinfection
AT franklindonaldr neurocognitivefunctioninginacuteorearlyhivinfection
AT gouauxben neurocognitivefunctioninginacuteorearlyhivinfection
AT leblancshannon neurocognitivefunctioninginacuteorearlyhivinfection
AT rosariodebra neurocognitivefunctioninginacuteorearlyhivinfection
AT fennemanotestinechristine neurocognitivefunctioninginacuteorearlyhivinfection
AT heatonrobertk neurocognitivefunctioninginacuteorearlyhivinfection
AT ellisronaldj neurocognitivefunctioninginacuteorearlyhivinfection
AT atkinsonjhampton neurocognitivefunctioninginacuteorearlyhivinfection
AT grantigor neurocognitivefunctioninginacuteorearlyhivinfection
AT neurocognitivefunctioninginacuteorearlyhivinfection